On 2 June, 2016, the DRIVE-AB consortium, with support from the EU Presidency of the Netherlands, held a high-level conference on stimulating innovation, sustainable use and global access to antibiotics in Amsterdam. The event attracted more than 180 policy makers, regulatory and public health experts and economists to identify and evaluate reward models that are feasible, practical and can be implemented globally.
Discussions among the experts identified key gaps in global action and policy, mechanisms for ensuring sustainable use and new economic models to stimulate antibiotic innovation while ensuring access and sustainable use. The full conference report outlines the key messages and outcomes from these discussions in more detail.
The conference was followed on 3 June by an invitation-only workshop for key stakeholders to explore the feasibility of DRIVE-AB’s five preliminary reward models, which are now being re-evaluated in the context of the feedback received. A short report detailing the outcomes of this workshop will be available soon.
The full conference report detailing the discussions and outputs of this important meeting is now available: please click here to view the report.
A shorter conference summary is also available here.
Please click here to view conference slide sets.
Please click here to view the 2 June conference programme.
Please click here to read the pre-conference report.
Please click here to read a document containing more detailed information on the economic models that were discussed, DRIVE-AB’s preliminary findings regarding innovation incentives: Incentives to stimulate antibiotic innovation: The preliminary findings of DRIVE-AB.
